Home > Insider Trading > Filing (0001192482-15-000207)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267565	Collegium Pharmaceutical Inc	COLL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365617	J Patrick Heron	C/O Frazier Healthcare Vi, L.p. 601 Union Street, Suite 3200 Seattle WA 98101		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-05-12	582,490	$0.00	582,490	No	4	C	Indirect	By Frazier Healthcare VI, L.P.
Common Stock	Acquisiton	2015-05-12	222,231	$0.00	804,721	No	4	C	Indirect	By Frazier Healthcare VI, L.P.
Common Stock	Acquisiton	2015-05-12	392,113	$0.00	1,196,834	No	4	C	Indirect	By Frazier Healthcare VI, L.P.
Common Stock	Acquisiton	2015-05-12	540,498	$0.00	1,737,332	No	4	C	Indirect	By Frazier Healthcare VI, L.P.
Common Stock	Acquisiton	2015-05-12	150,000	$12.00	1,887,332	No	4	P	Indirect	By Frazier Healthcare VI, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Frazier Healthcare VI, L.P.
No	4	C	Indirect	By Frazier Healthcare VI, L.P.
No	4	C	Indirect	By Frazier Healthcare VI, L.P.
No	4	C	Indirect	By Frazier Healthcare VI, L.P.
No	4	P	Indirect	By Frazier Healthcare VI, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Stock	Disposition	2015-05-12	4,019,183	$0.00	582,490	$0.00
Common Stock	Series B Convertible Stock	Disposition	2015-05-12	1,533,399	$0.00	222,231	$0.00
Common Stock	Series C Convertible Stock	Disposition	2015-05-12	2,705,585	$0.00	392,113	$0.00
Common Stock	Series D Convertible Stock	Disposition	2015-05-12	3,676,078	$0.00	540,498	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

All series of Convertible Preferred Stock automatically converted into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and had no expiration date.
Reflects the conversion of preferred stock into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis which became effective on May 12, 2015.
The shares are held by Frazier Healthcare VI, L.P. The general partner of Frazier Healthcare VI, L.P. is FHM VI, L.P., a limited partnership, the general partner of which is FHM VI, LLC. The members of FHM VI, LLC are Dr. Nathan Every, Alan Frazier, Nader Naini, Patrick Heron, and Dr. James Topper. These individuals share voting and investment power over the shares held by Frazier Healthcare VI, L.P. Mr. Heron disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.